The transmission interface of the saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in Drug resistance

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 2, 2013, Pages 1025-1034

  Downes, Marianne T ^a   Mehla, Jitender ^a   Ananthaswamy, Neeti ^a   Wakschlag, Adina ^a   Lamonde, Micheala ^b   Dine, Elliot ^a   Ambudkar, Suresh V ^b   Golin, John ^a  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; BIFONAZOLE; CERULENIN; CLIMBAZOLE; CLOTRIMAZOLE; CYCLOHEXIMIDE; CYPROCONAZOLE; CYPRODINIL; ENILCONAZOLE; PROTEIN PDR5; PYRROLE DERIVATIVE; TAMOXIFEN; TEBUCONAZOLE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME ACTIVITY; FUNGAL STRAIN; FUNGUS MUTANT; FUNGUS MUTATION; GENE EXPRESSION; GENETIC SCREENING; HYDROLYSIS; IC 50; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SACCHAROMYCES CEREVISIAE;

AMINO ACID SUBSTITUTION; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CYCLOHEXIMIDE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84872867465     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02133-12     Document Type: Article

References (26)

1. Borges-Walmsey MJ, McKeegan K, Walmsey AR. 2003. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376: 313-338.
2. Fojo AT, Whang-Peng J, Gottesman MM, Pastan I. 1985. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 82:7661-7665.
3. Gros P, Croop J, Roninson I, Varshavsky A, Housman DE. 1986. Isolation and characterization of DNA sequences amplified in multidrug resistant human cells. Proc. Natl. Acad. Sci. U. S. A. 83:337-341.
4. Roninson IB, Abelson HT, Housman DE, Howell N, Varshavsky A. 1984. Amplification of specific DNA sequences correlates with multidrug resistance in Chinese hamster cells. Nature 309:626-628.
5. Van der Bliek AM, Van der Velde-Koerts, Ling TV, Borst P. 1986. Overexpression and amplification of five genes in a multidrug resistant Chinese hamster ovary cell line. Mol. Cell. Biol. 6:1671-1678.
6. Rank GH, Bech-Hansen NJ. 1973. Single nuclear gene inherited crossresistance and collateral sensitivity to 17 inhibitors of mitochondrial function in Saccharomyces cerevisiae. Mol. Gen. Genet. 126:93-102.
7. Leppert G, McDevitt R, Falco SC, Van Dyk T, Ficke MB, Golin J. 1990. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics 125:13-20.
8. Balzi E, Wang M, Leterme S, Van Dyck L, Goffeau A. 1994. Pdr5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator Pdr1. J. Biol. Chem. 269:2206-2214.
9. Hirata D, Yano K, Miyahara K, Miyakawa R. 1994. Saccharomyces cerevisiae Ydr1, which encodes a member of the ATP-binding cassette superfamily, is required for multidrug resistance. Curr. Genet. 26:285-294.
10. Servos J, Haase E, Brendel M. 1993. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitoquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol. Gen. Genet. 236:214-218.
11. Bissinger PH, Kuchler K. 1994. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J. Biol. Chem. 269:4180-4186.
12. Katzmann DJ, Hallstrom TC, Voet M, Wysock W, Golin J, Volckaert G, Moye-Rowley WS. 1995. Expression of an ATP-binding cassette transporter gene YOR1 is required for oligomycin resistance in Saccharomyces cerevisiae. Mol. Cell. Biol. 15:6875-6883.
13. Meyers S, Schauer W, Balzi E, Wagner M, Goffeau A, Golin J. 1992. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr. Genet. 21:431-436.
14. Golin J, Ambudkar SV, Gottesman MM, Habib AD, Sczepanski J, Ziccardi W, May L. 2003. Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J. Biol. Chem. 278: 5963-5969.
15. Rogers B, Decottignies A, Kolaczkowski M, Caravajal E, Balzi E, Goffeau A. 2001. The pleiotropic drug ABC transporters from Saccharomyces cerevisiae. J. Mol. Microbiol. Biotechnol. 3:207-214.
16. Rutledge R, Esser L, Ma J, Xia D. 2011. Toward and understanding of the mechanism of action of the yeast multidrug resistance transporter Pdr5p: A molecular modeling study. J. Struct. Biol. 173:333-344.
17. Oancea G, O'Mara ML, Drew-Bennett W, Tielman P, Abeles R, Tampe R. 2009. Structural arrangement of the transmission interface of the antigen ABC transport complex TAP. Proc. Natl. Acad. Sci. U. S. A. 106:5551-5556.
18. Zolnerciks JK, Wooding C, Linton KJ. 2007. Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB J. 21:3937-3948.
19. Dawson RJ, Locher KP. 2006. Structure of a bacterial multidrug ABC transporter. Nature 443:180-185.
20. Sauna ZE, Bohn SS, Rutledge R, Dougherty MP, Cronin S, May L, Xia D, Ambudkar SV, Golin J. 2008. Mutations define cross talk between the N-terminal nucleotide-binding domain and transmembrane helix-2 of the yeast multidrug transporter Pdr5: Possible conservation of a signaling interface for coupling ATP hydrolysis to drug transport. J. Biol. Chem. 283:35010-35022.
21. Ananthaswamy N, Rutledge R, Sauna ZE, Dine E, Nelson E, Xia D, Golin J. 2010. The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation and there are functional overlap and equivalence of the deviant and canonical Q-loop residues. Biochemistry 49:4440-4449.
22. Golin J, Kon ZN, Wu CP, Martello J, Hanson L, Supernavage S, Ambudkar SV, Sauna Z. 2007. Complete inhibition of the Pdr5p multidrug efflux pump ATPase activity by its transport substrate clotrimazole suggests GTP as well as ATP may be used as an energy source. Biochemistry 46:18109-18119.
23. Guo X, Li J, Wang T, Liu Z, Chen X, Li Y, Gu Z, Mao X, Guan W, Li Y. 2012. A mutation in intracellular loop 4 affects the drug efflux activity of the yeast multidrug transporter Pdr5p. PLoS One 7:e29520. doi:10.1371 /journal.pone.0029520.
24. Ernst R, Kueppers P, Klein CM, Schwarzmueller T, Kuchler K, Schmitt L. 2008. A mutation of the H-loop selectively affects rhodamine transport by the yeast ABC transporter Pdr5. Proc. Natl. Acad. Sci. U. S. A. 105: 5069-5074.
25. Aller S, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Urbatsch IL, Chang G. 2009. Structure of P-glycoprotein reveals a molecular basis for polyspecific drug binding. Science 323:1718-1722.
26. Hanson L, May L, Tuma P, Keeven J, Mehl P, Ferenz M, Ambudkar SV, Golin J. 2005. The role of hydrogen bond acceptor groups in the interaction of substrates with Pdr5, a major yeast drug transporter. Biochemistry 44:9703-9713.